tactile logo     Print Page | Close Window

Investor Overview

Stock Price

NASDAQ TCMD (Common Stock) $19.07 + 0.62
April 24, 20174:00 p.m. ET
Data provided by Nasdaq. Minimum 15 minutes delayed.

Investor Presentation

Download Documentation Q4 2016 Investor Presentation

Annual Reports

Download Documentation 2016 Annual Report to Stockholders

Company Overview

Tactile Medical is a leader in treatment options for lymphedema and venous ulcer therapies. Tactile Medical develops advanced home therapy devices to improve health and quality of life for patients with chronic swelling conditions. Headquartered in Minneapolis, Minnesota, we advocate for patient access and serve tens of thousands of patients through a national network of product specialists and trainers, reimbursement experts, patient advocates, and clinical staff. Our products are proven to improve quality of life, increase clinical efficacy, and reduce overall healthcare costs.

Recent News

Tactile Medical to Participate in Upcoming Investor Conferences in May

April 20, 2017

MINNEAPOLIS, April 20, 2017 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical... 

Read More >

Tactile Medical to Release First Quarter 2017 Financial Results on May 8, 2017

April 10, 2017

MINNEAPOLIS, April 10, 2017 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical... 

Read More >